Lyn mitigates mouse airway remodeling by downregulating the TGF-β3 isoform in house dust mite models

Guoping Li1, John Fox, Zhigang Liu

  • 1Department of Biochemistry and Molecular Biology, University of North Dakota, Grand Forks, ND 58203;

Insights

The protein Lyn regulates airway remodeling in asthma by controlling TGF-β3. Loss of Lyn worsens asthma symptoms, suggesting Lyn as a therapeutic target for severe chronic asthma.

Area of Science:

  • Immunology
  • Cell Biology
  • Pulmonology

Background:

  • Chronic airway remodeling is a severe complication of asthma with poorly understood mechanisms.
  • The specific role of the protein Lyn in airway remodeling is currently undefined.

Purpose of the Study:

  • To investigate the role of Lyn in chronic airway remodeling.
  • To explore the relationship between Lyn, TGF-β3, and asthma severity.

Main Methods:

  • Utilized Lyn knockout (Lyn-/-) mice exposed to house dust mite extracts.
  • Analyzed lung tissue for inflammation, mucus production, collagen deposition, and cytokine profiles.
  • Investigated the effects of TGF-β3 on cellular processes and gene expression.
  • Correlated Lyn levels with asthma severity in human patients.

Main Results:

  • Lyn deficiency exacerbated airway remodeling, increasing mucus, collagen, inflammation, and dysregulated cytokines.
  • Increased TGF-β3, but not TGF-β1, was observed in Lyn-/- mouse lungs.
  • TGF-β3 inhibition reduced STAT6, Smad2/3, and NF-κB activation.
  • TGF-β3 promoted epithelial-to-mesenchymal transition and MUC5AC expression.
  • Reduced Lyn levels correlated with increased airway inflammation and mucus in asthma patients.

Conclusions:

  • Lyn plays a critical role in regulating airway remodeling, potentially by interacting with TGF-β3.
  • Targeting Lyn or TGF-β3 may offer therapeutic strategies for severe chronic asthma.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
360
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
77